Here are a few stocks to keep

Here are a few stocks to keep an eye on this week, along with some key structural catalysts.

$NEBIUS(NBIS)$ , $Rocket Lab USA, Inc.(RKLB)$ , $CoreWeave, Inc.(CRWV)$ : These officially join the Nasdaq 100 on Monday, which should drive institutional inflows. Notably, $CoreWeave, Inc.(CRWV)$ (CoreWeave) has a $99.4B backlog and a signed $21B infrastructure deal with Meta.

$Hims & Hers Health Inc.(HIMS)$ : This is backed by a $1.17M insider buy, with the late-July FDA peptide meeting serving as a potential major tailwind.

$Oscar Health, Inc.(OSCR)$ : The CEO recently made an $11.9M insider purchase, signaling a strong fundamental path toward higher macro targets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":577737604870400,"tweetId":"577737604870400","gmtCreate":1782070253000,"gmtModify":1782113091002,"author":{"id":9000000000000195,"idStr":"9000000000000195","authorId":9000000000000195,"authorIdStr":"9000000000000195","name":"TimothyBarnes","avatar":"https://static.tigerbbs.com/106a411ceff67f0e60547585f11948b5","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":91,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/4ea63595a5794ca9802e610f47466e33","width":"1122","height":"1402"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/4ea63595a5794ca9802e610f47466e33","width":"1122","height":"1402"}],"title":"","html":"<html><head></head><body>Here are a few stocks to keep an eye on this week, along with some key structural catalysts.\n<a href=\"https://ttm.financial/S/NBIS\">$NEBIUS(NBIS)$&nbsp;</a>, <a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a>, <a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$&nbsp;</a>: These officially join the Nasdaq 100 on Monday, which should drive institutional inflows. Notably, <a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$&nbsp;</a> (CoreWeave) has a $99.4B backlog and a signed $21B infrastructure deal with Meta.\n<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$&nbsp;</a>: This is backed by a $1.17M insider buy, with the late-July FDA peptide meeting serving as a potential major tailwind.\n<a href=\"https://ttm.financial/S/OSCR\">$Oscar Health, Inc.(OSCR)$&nbsp;</a>: The CEO recently made an $11.9M insider purchase, signaling a strong fundamental path toward higher macro targets.\n<img src=\"https://community-static.tradeup.com/news/4ea63595a5794ca9802e610f47466e33\" tg-width=\"1122\" tg-height=\"1402\"></body></html>","htmlText":"<html><head></head><body>Here are a few stocks to keep an eye on this week, along with some key structural catalysts.\n<a href=\"https://ttm.financial/S/NBIS\">$NEBIUS(NBIS)$&nbsp;</a>, <a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a>, <a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$&nbsp;</a>: These officially join the Nasdaq 100 on Monday, which should drive institutional inflows. Notably, <a href=\"https://ttm.financial/S/CRWV\">$CoreWeave, Inc.(CRWV)$&nbsp;</a> (CoreWeave) has a $99.4B backlog and a signed $21B infrastructure deal with Meta.\n<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$&nbsp;</a>: This is backed by a $1.17M insider buy, with the late-July FDA peptide meeting serving as a potential major tailwind.\n<a href=\"https://ttm.financial/S/OSCR\">$Oscar Health, Inc.(OSCR)$&nbsp;</a>: The CEO recently made an $11.9M insider purchase, signaling a strong fundamental path toward higher macro targets.\n<img src=\"https://community-static.tradeup.com/news/4ea63595a5794ca9802e610f47466e33\" tg-width=\"1122\" tg-height=\"1402\"></body></html>","text":"Here are a few stocks to keep an eye on this week, along with some key structural catalysts. $NEBIUS(NBIS)$ , $Rocket Lab USA, Inc.(RKLB)$ , $CoreWeave, Inc.(CRWV)$ : These officially join the Nasdaq 100 on Monday, which should drive institutional inflows. Notably, $CoreWeave, Inc.(CRWV)$ (CoreWeave) has a $99.4B backlog and a signed $21B infrastructure deal with Meta. $Hims & Hers Health Inc.(HIMS)$ : This is backed by a $1.17M insider buy, with the late-July FDA peptide meeting serving as a potential major tailwind. $Oscar Health, Inc.(OSCR)$ : The CEO recently made an $11.9M insider purchase, signaling a strong fundamental path toward higher macro targets.","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/577737604870400","repostId":0,"isVote":1,"tweetType":1,"viewCount":413,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RKLB","NBIS","CRWV","HIMS","OSCR"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":564,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/577737604870400"}